DRUG

infliximab

2 hypotheses across 2 therapeutic domains

ALL HYPOTHESES

Repurposing candidates for infliximab

Epilepsy 1

Mediator Outcome Score Tier Lit. status Trial
MMP-9 epilepsy 0.277 High reproduces known none

Rheumatoid arthritis 1

Mediator Outcome Score Tier Lit. status Trial
IL-34 bone erosion 0.208 Mid reproduces known completed

Clinical trials

200 registered trials for infliximab

Source: ClinicalTrials.gov